Risk-benefit study: stopping antibiotics in RVP-positive pneumonia

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF THE ASSISTANT SECRETARY FOR FINANCIAL RESOURCES (ASFR).OMAS STRATEGIC BUYING CENTER - HHS MISSION
Country
United States
Closing Date
Not specified
Estimated Value
Not disclosed

Summary

HHS Office of the Assistant Secretary for Financial Resources (OMAS) is conducting a sources-sought for a risk-benefit assessment of stopping antibiotics in Respiratory Viral Panel positive inpatients with non-severe community-acquired pneumonia. Scope covers clinical research design and execution under NAICS 541715. Federal research procurement.

Full Description

https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=ca730ae566c247c3bf1bb1ccbb43267d

Want tenders like this emailed daily?

Get matched government contracts for your industry every morning. Free forever, with plain-English summaries and direct bid links.

Sign Up Free

Similar Tenders